BNTX Latest Press Releases

-- December 18, 2025 --

BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field Globe Newswire 4:45 AM

-- December 9, 2025 --

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer Globe Newswire 7:00 AM

-- December 6, 2025 --

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer Globe Newswire 3:30 PM

-- December 3, 2025 --

BioNTech Achieves Minimum Condition in CureVac Exchange Offer Globe Newswire 9:01 AM

-- November 26, 2025 --

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration Globe Newswire 7:30 AM

-- November 3, 2025 --

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update Globe Newswire 6:45 AM

-- October 28, 2025 --

BioNTech to Host Innovation Series R&D Day on November 11, 2025 Globe Newswire 7:45 AM

-- October 27, 2025 --

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025 Globe Newswire 7:45 AM

-- October 22, 2025 --

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V. Globe Newswire 6:45 AM

-- September 23, 2025 --

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025 Globe Newswire 6:45 AM

-- September 8, 2025 --

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity Globe Newswire 11:00 AM

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula Business Wire 6:45 AM

-- September 1, 2025 --

??? ??? ???? ???? ? ?? '??' ??? ???? ? CDC ?? ???? ???: '?? ??? ???'? ?? ? Shomik Sen Bhattacharjee 3:47 AM

Le leadership de Robert Kennedy Jr. ne peut apporter que plus de "dommages", dclare un haut responsable de l'ancien CDC : "Le dmantlement de la vaccination" est en cours Shomik Sen Bhattacharjee 3:47 AM

????????Jr.???????????CDC????????????????????????????????????????????? Shomik Sen Bhattacharjee 3:47 AM

??? ???? ?????? ????? ?????? ??????? ??????: "????? ????? ?????? ?????? ?????? ??? ????? ?????? ?? ?????: '????? ???????' ?? ???????". Shomik Sen Bhattacharjee 3:47 AM

??????????????????"??",?????????????:"???????????" Shomik Sen Bhattacharjee 3:47 AM

Il leadership di Robert Kennedy Jr. pu solo portare pi "danno", afferma il ex funzionario di alto livello dei CDC: "Disfazione della vaccinazione" in corso Shomik Sen Bhattacharjee 3:47 AM

Robert Kennedy Jr.'s Fhrung wird laut einem fhrenden ehemaligen CDC-Beamten nur noch mehr "Schaden" bringen: "Rckgngigmachung der Impfung" in Arbeit Shomik Sen Bhattacharjee 3:47 AM

El liderazgo de Robert Kennedy Jr. solo puede traer ms "dao", dice alto exfuncionario de los CDC: "Desmantelamiento de la vacunacin" en proceso Shomik Sen Bhattacharjee 3:47 AM

Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works Shomik Sen Bhattacharjee 3:46 AM

-- August 31, 2025 --

?? ?????, ???, ??? ? ??? ??? ??? 10?? (8? 25?~29?) Nabaparna Bhattacharya 6:55 PM

?? ?????, ???, ??? ? ??? ??? ??? 10?? (8? 25?~29?) Nabaparna Bhattacharya 6:54 PM

?? ?????, ???, ??? ???? ???(8? 25?~8? 29?) ??? ?? 10? ?? ?????: ??? ??????? ?? ???? ???? Nabaparna Bhattacharya 9:49 AM

Marvell Technology, eBay und DexCom gehren zu den Top 10 der groen Verlierer der letzten Woche (25. August - 29. August): Sind die anderen in Ihrem Portfolio? Nabaparna Bhattacharya 9:48 AM

Marvell Technology, eBay e DexCom sono tra i primi 10 grandi perdenti della scorsa settimana (25-29 agosto): sono presenti gli altri nel tuo portafoglio? Nabaparna Bhattacharya 9:48 AM

????? ??????? ?????? ???????? ?? ????? ?????? ?????? ???????? ?? ??????? ?????? (25 ????? - 29 ?????): ?? ?????? ?? ??????? Nabaparna Bhattacharya 9:48 AM

Marvell Technology, eBay y DexCom se encuentran entre los 10 principales perdedores de gran capitalizacin la semana pasada (del 25 al 29 de agosto): Estn los dems en su cartera? Nabaparna Bhattacharya 9:48 AM

Marvell Technology, eBay et DexCom font partie des 10 plus grandes baisses de la semaine dernire (25 aot - 29 aot) : Sont-ils galement dans votre portefeuille ? Nabaparna Bhattacharya 9:48 AM

??????????10????????Marvell Technology?eBay????DexCom????????(8?25??8?29?)???????????????????????? Nabaparna Bhattacharya 9:48 AM

??(8?25??8?29?),Marvell Technology?eBay?DexCom?????????????,?????????????? Nabaparna Bhattacharya 9:48 AM

Marvell Technology, eBay, And DexCom Are Among Top 10 Large Cap Losers Last Week (August 25-August 29): Are The Others In Your Portfolio? Nabaparna Bhattacharya 9:48 AM

-- August 27, 2025 --

Pfizer and BioNTech's COMIRNATY Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19 Globe Newswire 12:50 PM

Pfizer and BioNTech's COMIRNATY Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19 Business Wire 12:50 PM

-- August 18, 2025 --

The Next Wave of Cancer Innovation: How Breakthrough Therapies Are Redefining Treatment Paradigms Yolowire 7:40 AM

-- August 4, 2025 --

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update Globe Newswire 6:45 AM